Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|23|3373-3383

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.23, 2015-01, pp. : 3373-3383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatments in context: transcranial direct current brain stimulation as a potential treatment in pediatric psychosis

By David Christopher N   Rapoport Judith L   Gogtay Nitin  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 447-458

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Directions in T2DM

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial

By Brunoni André   Machado-Vieira Rodrigo   Zarate Carlos   Valiengo Leandro   Vieira Erica   Benseñor Isabela   Lotufo Paulo   Gattaz Wagner   Teixeira Antonio  

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1315-1323

Springer Publishing Company

Access to resources Recommend Favorite

Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

By Morrissey Ryan P.   Czer Lawrence   Shah Prediman K.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 153-171

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite